Linifanib – a multi-targeted receptor tyrosine kinase inhibitor and a low molecular weight gelator
In this study we demonstrate that linifanib, a multi-targeted receptor tyrosine kinase inhibitor, with a key urea containing pharmacophore, self-assembles into a hydrogel in the presence of low amounts of solvent. We demonstrate the role of the urea functional group and that of fluorine substitution...
| Main Authors: | Marlow, Maria, Al-Ameedee, Mohammed, Smith, Thomas, Wheeler, Simon, Stocks, Michael J. |
|---|---|
| Format: | Article |
| Published: |
Royal Society of Chemistry
2015
|
| Online Access: | https://eprints.nottingham.ac.uk/48294/ |
Similar Items
Self-assembling tyrosine kinase inhibitors for localised targeted delivery
by: Al-Ameedee, Mohammed
Published: (2017)
by: Al-Ameedee, Mohammed
Published: (2017)
Benzalhydantoin derivative-based inhibitors of eight receptor tyrosine kinases: synthesis, in-vitro, and in-silico study
by: Muhammad Naufal,, et al.
Published: (2025)
by: Muhammad Naufal,, et al.
Published: (2025)
An investigation into the effects of the epidermal growth factor receptor tyrosine kinase inhibitor "Gefitinib" on human breast cancer
by: Gutteridge, Eleanor
Published: (2010)
by: Gutteridge, Eleanor
Published: (2010)
Effects of 4 multitargeted receptor tyrosine kinase inhibitors on regional hemodynamics in conscious, freely moving rats
by: Carter, Joanne J., et al.
Published: (2016)
by: Carter, Joanne J., et al.
Published: (2016)
An apoferritin-based drug delivery system for the tyrosine kinase inhibitor gefitinib
by: Kuruppu, Anchala I., et al.
Published: (2015)
by: Kuruppu, Anchala I., et al.
Published: (2015)
Resistance mechanisms causing first-line epidermal growth factor receptor-tyrosine kinase inhibitor treatment failure
by: Chai, C.S., et al.
Published: (2017)
by: Chai, C.S., et al.
Published: (2017)
Self-assembling benzothiazole-based gelators: a mechanistic understanding of in vitro bioactivation and gelation
by: Citossi, Francesca, et al.
Published: (2018)
by: Citossi, Francesca, et al.
Published: (2018)
EGFR-directed tyrosine kinase inhibitors for non-small cell lung cancer
by: Fatin Nur Elyana Mohd Sidek,, et al.
Published: (2025)
by: Fatin Nur Elyana Mohd Sidek,, et al.
Published: (2025)
Case Series of Small Cell Lung Cancer Transformation
as Resistance Mechanism to Epidermal Growth Factor
Receptor-Tyrosine Kinase Inhibitor
by: Liam, C, et al.
Published: (2017)
by: Liam, C, et al.
Published: (2017)
Real-time analysis of the binding of fluorescent VEGF₁₆₅a to VEGFR2 in living cells: Effect of receptor tyrosine kinase inhibitors and fate of internalized agonist-receptor complexes
by: Kilpatrick, Laura E., et al.
Published: (2017)
by: Kilpatrick, Laura E., et al.
Published: (2017)
Adaptive therapy to circumvent drug resistance to tyrosine kinase inhibitors in cancer: is it clinically relevant?
by: Hamdi, Amir Imran Faisal, et al.
Published: (2022)
by: Hamdi, Amir Imran Faisal, et al.
Published: (2022)
Outcome of patients with advanced lung adenocarcinoma treated with first-line epidermal growth factor receptor tyrosine kinase inhibitors versus cytotoxic chemotherapy
by: Chai, Chee She
Published: (2015)
by: Chai, Chee She
Published: (2015)
Determination of gene expression of tyrosine kinase receptors (HER family) in FFPE tissue of colorectal adenocarcinoma
by: Othman @ Jaffar, Rosfayati, et al.
Published: (2015)
by: Othman @ Jaffar, Rosfayati, et al.
Published: (2015)
Case series of small cell lung cancer transformation post tyrosine kinase inhibitor failure
by: Chai, C.S., et al.
Published: (2017)
by: Chai, C.S., et al.
Published: (2017)
Spectroscopic and molecular modeling studies on the interaction of tyrosine kinase inhibitors with human serum albumin / Md. Zahirul Kabir
by: Md. Zahirul , Kabir
Published: (2018)
by: Md. Zahirul , Kabir
Published: (2018)
Effects of receptor tyrosine kinase inhibitors on VEGF165a- and VEGF165b-stimulated gene transcription in HEK-293 cells expressing human VEGFR2
by: Carter, Joanne J., et al.
Published: (2015)
by: Carter, Joanne J., et al.
Published: (2015)
Small Cell Transformation and T790M Mutation as
Coresistance Mechanisms for First-line Epidermal
Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy Failure
by: Chee, Shee Chai
Published: (2017)
by: Chee, Shee Chai
Published: (2017)
A phase 2 trial of decreasing tyrosine kinase inhibitor dose in chronic myeloid leukaemia patients with stable major molecular response: data from the British DESTINY study
by: Clark, Richard E., et al.
Published: (2017)
by: Clark, Richard E., et al.
Published: (2017)
Gelation properties of self-assembling N-acyl modified cytidine derivatives
by: Skilling, Kathryn J., et al.
Published: (2014)
by: Skilling, Kathryn J., et al.
Published: (2014)
Amino acid functionalised calixarenes: crystal growth modifiers and low molecular weight gelators
by: Goh, Ching Yong
Published: (2012)
by: Goh, Ching Yong
Published: (2012)
Macrocyclic gelators
by: Goh, Ching, et al.
Published: (2013)
by: Goh, Ching, et al.
Published: (2013)
Survival rate and prognostic factors of survival among chronic myeloid leukaemia adults after initiation of tyrosine kinase inhibitor therapy in Hospital Ampang, Selangor
by: Ali, Zakiah Bakar
Published: (2024)
by: Ali, Zakiah Bakar
Published: (2024)
Low molecular weight nucleoside gelator: A novel approach for protein and peptide aggregation inhibition
by: Johnson, Litty
Published: (2019)
by: Johnson, Litty
Published: (2019)
Role of Focal Adhesion Tyrosine Kinases in GPVI-Dependent Platelet Activation and Reactive Oxygen Species Formation
by: Carrim, N., et al.
Published: (2014)
by: Carrim, N., et al.
Published: (2014)
Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules
by: Yu, Yu, et al.
Published: (2015)
by: Yu, Yu, et al.
Published: (2015)
The focal adhesion kinase Pyk2 links Ca2+ signalling to Src family kinase activation and protein tyrosine phosphorylation in thrombin-stimulated platelets
by: Canobbio, I., et al.
Published: (2015)
by: Canobbio, I., et al.
Published: (2015)
A randomized control trial comparing peginterferon-α-2a versus observation after stopping tyrosine kinase inhibitor in chronic myeloid leukemia with deep molecular response for at least two years
by: Kuan, Jew-Win, et al.
Published: (2016)
by: Kuan, Jew-Win, et al.
Published: (2016)
The proline-rich tyrosine kinase Pyk2 regulates platelet integrin aIIbß3 outside-in signaling
by: Cipolla, L., et al.
Published: (2013)
by: Cipolla, L., et al.
Published: (2013)
Inhibition of transforming growth factor-β via the activin receptor-like kinase-5 inhibitor attenuates pulmonary fibrosis
by: Koh, Rhun Yian, et al.
Published: (2015)
by: Koh, Rhun Yian, et al.
Published: (2015)
Kinase targets in CNS drug discovery
by: Gunosewoyo, Hendra, et al.
Published: (2017)
by: Gunosewoyo, Hendra, et al.
Published: (2017)
Editorial: Platelet hem-Immunoreceptor Tyrosine-Based Activation Motif Receptors: At Lease One Required
by: Berndt, Michael, et al.
Published: (2013)
by: Berndt, Michael, et al.
Published: (2013)
Characterisation of Gelation by Atomic Force Microscopy
by: Barker, Emily Clare
Published: (2020)
by: Barker, Emily Clare
Published: (2020)
Impaired thrombin-induced platelet activation and thrombus formation in mice lacking the Ca2+-dependent tyrosine kinase Pyk2
by: Canobbio, I., et al.
Published: (2013)
by: Canobbio, I., et al.
Published: (2013)
Src family tyrosine kinase Lyn mediates VWF GPIb-IX induced platelet activation via the cGMP signaling pathway
by: Yin, H., et al.
Published: (2008)
by: Yin, H., et al.
Published: (2008)
Effects of vertical confinement on gelation and sedimentation of colloids
by: Razali, Azaima, et al.
Published: (2017)
by: Razali, Azaima, et al.
Published: (2017)
Fish gelation in skin and bone tissue engineering
by: Syazwani Ramli,, et al.
Published: (2019)
by: Syazwani Ramli,, et al.
Published: (2019)
Low molecular mass nucleoside gelators for intra-tumoural drug delivery
by: Skilling, Kathryn J.
Published: (2016)
by: Skilling, Kathryn J.
Published: (2016)
Design and elaboration of a tractable tricyclic scaffold to synthesize druglike inhibitors of dipeptidyl peptidase-4 (DPP-4), antagonists of the C–C Chemokine Receptor Type 5 (CCR5), and highly potent and selective phosphoinositol-3 Kinase δ (PI3Kδ) inhibitors
by: Schwehm, Carolin, et al.
Published: (2017)
by: Schwehm, Carolin, et al.
Published: (2017)
Cyclin dependent Kinases as potential therapeutic targets for atherosclerosis
by: Rostam, Muhamad Ashraf, et al.
Published: (2015)
by: Rostam, Muhamad Ashraf, et al.
Published: (2015)
Kinase Targets for Mycolic Acid Biosynthesis in Mycobacterium tuberculosis.
by: Alsayed, S., et al.
Published: (2018)
by: Alsayed, S., et al.
Published: (2018)
Similar Items
-
Self-assembling tyrosine kinase inhibitors for localised targeted delivery
by: Al-Ameedee, Mohammed
Published: (2017) -
Benzalhydantoin derivative-based inhibitors of eight receptor tyrosine kinases: synthesis, in-vitro, and in-silico study
by: Muhammad Naufal,, et al.
Published: (2025) -
An investigation into the effects of the epidermal growth factor receptor tyrosine kinase inhibitor "Gefitinib" on human breast cancer
by: Gutteridge, Eleanor
Published: (2010) -
Effects of 4 multitargeted receptor tyrosine kinase inhibitors on regional hemodynamics in conscious, freely moving rats
by: Carter, Joanne J., et al.
Published: (2016) -
An apoferritin-based drug delivery system for the tyrosine kinase inhibitor gefitinib
by: Kuruppu, Anchala I., et al.
Published: (2015)